Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer.

Cancer investigation - 1 Dec 2010

Keller James, Shroyer Kenneth R, Batajoo Shishir K, Zhao Hong-Ling, Dong Li Ming, Hayman Michael J, Chan Edward L

Abstract excerpt

Epidermal growth factor receptor (EGFR) is a target in head and neck cancer. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. The aim of this study is to determine if clinical biological correlates are more accurate when different aspects of EGFR are evaluated in combination. We analyzed the EGFR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Immunohistochemistry

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Phosphorylation

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 20873989
DOI: 10.3109/07357907.2010.512602
PMCID: PMC2983479

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer.PMID 20873989Read ↗

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patientsSemantic proximity Read ↗

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).Semantic proximity Read ↗

Mutations in EGFR signal pathway in correlation with response to treatment of head and neck cancers.Semantic proximity Read ↗

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.Semantic proximity Read ↗

Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck CancerSemantic proximity Read ↗

Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Semantic proximity Read ↗

EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technologySemantic proximity Read ↗

Functional mutation analysis of EGFR family genes and corresponding lymph node metastases in head and neck squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.